title: 5-Fluorouracil in progressive systemic sclerosis: is it safe?
authors.forename: A N
authors.initials: AN
authors.lastname: Malaviya
authors.forename: R R
authors.initials: RR
authors.lastname: Singh
authors.forename: A
authors.initials: A
authors.lastname: Dhar
authors.forename: Y K
authors.initials: YK
authors.lastname: Gupta
authors.forename: A
authors.initials: A
authors.lastname: Kumar
authors.forename: P
authors.initials: P
authors.lastname: Agarwal
authors.forename: R
authors.initials: R
authors.lastname: Mathur
authors.forename: N K
authors.initials: NK
authors.lastname: Bhide
mesh_terms: D002986:Clinical Trials as Topic; D005472:Fluorouracil / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D012595:Scleroderma, Systemic / Q000188:drug therapy*
chemical_list: D005472:Fluorouracil